Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Charpentier

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Bulletin De L'Academie Nationale De Medecine|February 26, 2009
[New therapeutic targets for antibodies and recombinant proteins in organ transplantation]Bernard Charpentier
Bulletin De L'Academie Nationale De Medecine|January 18, 2005
[Recurrent kidney disease and its prevention after renal transplantation. Review of the literature]Bernard Charpentier
Expert Review of Clinical Immunology|November 22, 2012
Belatacept: a novel immunosuppressive agent for kidney transplant recipientsBernard Charpentier
Bulletin De L'Academie Nationale De Medecine|September 2, 2009
[Organ transplantation in old age]Bernard Charpentier
Current Opinion in Molecular Therapeutics|April 27, 2007
New therapeutic targets for antibodies and recombinant proteins in organ transplantationCaroline Créput, Antoine Durrbach, Benjamin Deroure, et al.
Bulletin De L'Academie Nationale De Medecine|May 30, 2015
[Necessary but sometimes complicated coordination of healthcare procedures. The example of chronic renal failure]Bernard Charpentier, Hélène François, Séverine Beaudreuil, et al.
Expert Opinion on Drug Safety|December 5, 2012
Belatacept utilization recommendations: an expert positionJosep M Grinyó, Klemens Budde, Franco Citterio, et al.
Current Opinion in Organ Transplantation|July 16, 2010
Co-signals in organ transplantationAntoine Durrbach, Hélène Francois, Antoine Jacquet, et al.
Nephrologie & Therapeutique|March 13, 2016
[Role of cannabinoid receptors in renal diseases]Hélène François, Antoine Durrbach, Séverine Beaudreuil, et al.
Nature Reviews. Nephrology|February 4, 2010
Advances in immunosuppression for renal transplantationAntoine Durrbach, Helene Francois, Severine Beaudreuil, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Bulletin De L'Academie Nationale De Medecine|February 26, 2009
[New therapeutic targets for antibodies and recombinant proteins in organ transplantation]Bernard Charpentier
Bulletin De L'Academie Nationale De Medecine|January 18, 2005
[Recurrent kidney disease and its prevention after renal transplantation. Review of the literature]Bernard Charpentier
Expert Review of Clinical Immunology|November 22, 2012
Belatacept: a novel immunosuppressive agent for kidney transplant recipientsBernard Charpentier
Bulletin De L'Academie Nationale De Medecine|September 2, 2009
[Organ transplantation in old age]Bernard Charpentier
Current Opinion in Molecular Therapeutics|April 27, 2007
New therapeutic targets for antibodies and recombinant proteins in organ transplantationCaroline Créput, Antoine Durrbach, Benjamin Deroure, et al.
Bulletin De L'Academie Nationale De Medecine|May 30, 2015
[Necessary but sometimes complicated coordination of healthcare procedures. The example of chronic renal failure]Bernard Charpentier, Hélène François, Séverine Beaudreuil, et al.
Expert Opinion on Drug Safety|December 5, 2012
Belatacept utilization recommendations: an expert positionJosep M Grinyó, Klemens Budde, Franco Citterio, et al.
Current Opinion in Organ Transplantation|July 16, 2010
Co-signals in organ transplantationAntoine Durrbach, Hélène Francois, Antoine Jacquet, et al.
Nephrologie & Therapeutique|March 13, 2016
[Role of cannabinoid receptors in renal diseases]Hélène François, Antoine Durrbach, Séverine Beaudreuil, et al.
Nature Reviews. Nephrology|February 4, 2010
Advances in immunosuppression for renal transplantationAntoine Durrbach, Helene Francois, Severine Beaudreuil, et al.
Pageof 9